Reversal of small, dense LDL subclass phenotype by weight loss is associated with impaired fat oxidation.
Adiposity is more prevalent among individuals with a predominance of small, dense low-density lipoprotein (LDL) (pattern B) particles than among those with larger LDL (pattern A). We tested for differences in resting energy expenditure (REE) and respiratory quotient (RQ) in overweight men with pattern A (n = 36) or pattern B (n = 60). Men consumed a standardized isoenergetic diet for 3 weeks after which a ~9 kg weight loss was induced by caloric deficit for 9 weeks, followed by 4 weeks of weight stabilization. REE and RQ were measured by indirect calorimetry before and after weight loss. Results were analyzed separately in pattern B men who converted to pattern A (B→A; n = 35) and those who did not (B→B; n = 25). At baseline, B→B men had higher trunk fat, triacylglycerol (TG) and insulin concentrations, homeostasis model assessment of insulin resistance (HOMA(IR)), and smaller LDL particles compared to B→A men and baseline pattern A men who remained pattern A (A→A; n = 35). REE normalized to fat-free mass did not change after weight loss. RQ decreased in A→A men, increased in B→A men, and did not change significantly in B→B men after weight loss. Calculated fat oxidation rates paralleled the RQ results. Baseline plasma TG concentrations were positively correlated with RQ and inversely correlated with the magnitude of weight loss achieved for a given prescribed energy reduction in the entire study population. Pattern B men who converted to pattern A with weight loss may have an underlying impairment in fat oxidation that predisposes to both dyslipidemia and an impaired ability to achieve weight loss by energy restriction.
Siri-Tarino
Patty W
PW
Atherosclerosis Research, Children's Hospital Oakland Research Institute, Oakland, California, USA.
Woods
Amy C
AC
Bray
George A
GA
Krauss
Ronald M
RM
D000328:Adult; D008078:Cholesterol, LDL / Q000737:chemistry / Q000145:classification / Q000378:metabolism*; D004038:Diet, Reducing; D004734:Energy Metabolism / Q000502:physiology; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D050356:Lipid Metabolism / Q000502:physiology; D052439:Lipid Metabolism Disorders / Q000097:blood / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D010316:Particle Size; D010641:Phenotype; D012146:Rest / Q000502:physiology; D016896:Treatment Outcome; D015431:Weight Loss / Q000502:physiology*
D008078:Cholesterol, LDL